Literature DB >> 10595542

X-ray crystallographic analysis of the structural basis for the interaction of pokeweed antiviral protein with guanine residues of ribosomal RNA.

I V Kurinov1, F Rajamohan, T K Venkatachalam, F M Uckun.   

Abstract

Pokeweed antiviral protein (PAP) is a ribosome-inactivating protein (RIP), which enzymatically removes a single adenine base from a conserved, surface exposed loop sequence of ribosomal rRNA. We now present unprecedented experimental evidence that PAP can release not only adenine but guanine as well from Escherichia coli rRNA, albeit at a rate 20 times slower than for adenine. We also report X-ray structure analysis and supporting modeling studies for the interactions of PAP with guanine. Our modeling studies indicated that PAP can accommodate a guanine base in the active site pocket without large conformational changes. This prediction was experimentally confirmed, since a guanine base was visible in the active site pocket of the crystal structure of the PAP-guanine complex.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595542      PMCID: PMC2144192          DOI: 10.1110/ps.8.11.2399

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  16 in total

Review 1.  Pokeweed antiviral protein: ribosome inactivation and therapeutic applications.

Authors:  J D Irvin; F M Uckun
Journal:  Pharmacol Ther       Date:  1992       Impact factor: 12.310

2.  The site of action of six different ribosome-inactivating proteins from plants on eukaryotic ribosomes: the RNA N-glycosidase activity of the proteins.

Authors:  Y Endo; K Tsurugi; J M Lambert
Journal:  Biochem Biophys Res Commun       Date:  1988-02-15       Impact factor: 3.575

3.  LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

Authors:  A C Wallace; R A Laskowski; J M Thornton
Journal:  Protein Eng       Date:  1995-02

4.  Inhibition of elongation factor 2-dependent translocation by the pokeweed antiviral protein and ricin.

Authors:  S L Gessner; J D Irvin
Journal:  J Biol Chem       Date:  1980-04-25       Impact factor: 5.157

5.  X-ray crystallographic analysis of the structural basis for the interactions of pokeweed antiviral protein with its active site inhibitor and ribosomal RNA substrate analogs.

Authors:  I V Kurinov; D E Myers; J D Irvin; F M Uckun
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

6.  Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials.

Authors:  D E Myers; J D Irvin; R S Smith; V M Kuebelbeck; F M Uckun
Journal:  J Immunol Methods       Date:  1991-02-15       Impact factor: 2.303

7.  X-ray analysis of substrate analogs in the ricin A-chain active site.

Authors:  A F Monzingo; J D Robertus
Journal:  J Mol Biol       Date:  1992-10-20       Impact factor: 5.469

8.  The 2.5 A structure of pokeweed antiviral protein.

Authors:  A F Monzingo; E J Collins; S R Ernst; J D Irvin; J D Robertus
Journal:  J Mol Biol       Date:  1993-10-20       Impact factor: 5.469

9.  Pokeweed antiviral protein inactivates pokeweed ribosomes; implications for the antiviral mechanism.

Authors:  M S Bonness; M P Ready; J D Irvin; T J Mabry
Journal:  Plant J       Date:  1994-02       Impact factor: 6.417

10.  Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies.

Authors:  J M Zarling; P A Moran; O Haffar; J Sias; D D Richman; C A Spina; D E Myers; V Kuebelbeck; J A Ledbetter; F M Uckun
Journal:  Nature       Date:  1990-09-06       Impact factor: 49.962

View more
  6 in total

1.  Structure-based design and engineering of a nontoxic recombinant pokeweed antiviral protein with potent anti-human immunodeficiency virus activity.

Authors:  Fatih M Uckun; Francis Rajamohan; Sharon Pendergrass; Zahide Ozer; Barbara Waurzyniak; Chen Mao
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

2.  CNS activity of Pokeweed anti-viral protein (PAP) in mice infected with lymphocytic choriomeningitis virus (LCMV).

Authors:  Fatih M Uckun; Larisa Rustamova; Alexei O Vassilev; Heather E Tibbles; Alexander S Petkevich
Journal:  BMC Infect Dis       Date:  2005-02-22       Impact factor: 3.090

Review 3.  Pokeweed antiviral protein, a ribosome inactivating protein: activity, inhibition and prospects.

Authors:  Artem V Domashevskiy; Dixie J Goss
Journal:  Toxins (Basel)       Date:  2015-01-28       Impact factor: 4.546

Review 4.  Ribosome-inactivating and related proteins.

Authors:  Joachim Schrot; Alexander Weng; Matthias F Melzig
Journal:  Toxins (Basel)       Date:  2015-05-08       Impact factor: 4.546

Review 5.  Pokeweed antiviral protein: its cytotoxicity mechanism and applications in plant disease resistance.

Authors:  Rong Di; Nilgun E Tumer
Journal:  Toxins (Basel)       Date:  2015-03-06       Impact factor: 4.546

6.  The C-terminal fragment of the ribosomal P protein complexed to trichosanthin reveals the interaction between the ribosome-inactivating protein and the ribosome.

Authors:  Priscilla Hiu-Mei Too; Meiji Kit-Wan Ma; Amanda Nga-Sze Mak; Yuen-Ting Wong; Christine Kit-Ching Tung; Guang Zhu; Shannon Wing-Ngor Au; Kam-Bo Wong; Pang-Chui Shaw
Journal:  Nucleic Acids Res       Date:  2008-12-10       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.